Publicação

Cognitive disorders in patients with chronic kidney disease

Ver documento

Detalhes bibliográficos
Resumo:Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including specificities of cognitive assessment in dialysis patients or after kidney transplantation; and available tests for screening and observed cognitive patterns in CKD patients.
Autores principais:Pépin, Marion
Outros Autores:Ferreira, Ana Carina; Arici, Mustafa; Bachman, Maie; Barbieri, Michelangela; Bumblyte, Inga Arune; Carriazo, Sol; Delgado, Pilar; Garneata, Liliana; Giannakou, Konstantinos; Godefroy, Olivier; Grodzicki, Tomasz; Klimkowicz-Mrowiec, Aleksandra; Kurganaite, Justina; Liabeuf, Sophie; Mocanu, Carmen Antonia; Paolisso, Giuseppe; Spasovski, Goce; Vazelov, Evgueniy Stefanov; Viggiano, Davide; Zoccali, Carmine; Massy, Ziad A; Więcek, Andrzej
Assunto:chronic kidney disease clinical assessment cognitive impairment cognitive screening test comprehensive battery Nephrology Transplantation
Ano:2022
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
Descrição
Resumo:Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including specificities of cognitive assessment in dialysis patients or after kidney transplantation; and available tests for screening and observed cognitive patterns in CKD patients.